Anti-influenza drug discovery: are we ready for the next pandemic? (Q30365120)

20 June 2017

title

Anti-influenza drug discovery: are we ready for the next pandemic? (English)

1 reference

20 June 2017

0 references

1 reference

1 reference

Tasneem Islam

1 reference

20 June 2017

Mark von Itzstein

series ordinal

1 reference

20 June 2017

publication date

1 January 2007

1 reference

Advances in Carbohydrate Chemistry and Biochemistry

20 June 2017

published in

1 reference

20 June 2017

1 reference

20 June 2017

page(s)

293-352

1 reference

20 June 2017

cites work

A history of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Prophylaxis and treatment of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Rimantadine: A Clinical Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza virus M2 protein has ion channel activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Neuraminidase inhibitors for the treatment and prevention of influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza virus neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Recent advances in anti-influenza agents with neuraminidase as target

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Functional balance between haemagglutinin and neuraminidase in influenza virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Sialic acid species as a determinant of the host range of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Crystals of a fragment of influenza haemagglutinin in the low pH induced conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The neuraminidase of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza virus neuraminidase: structure, antibodies, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The structure of the prosthetic group of bovine submaxillary gland mucoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Neuraminidase inhibitors for influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Two Nucleophilic Mutants of the Micromonospora viridifaciens Sialidase Operate with Retention of Configuration by Two Different Mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Contribution of the active site aspartic acid to catalysis in the bacterial neuraminidase from Micromonospora viridifaciens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Mutagenesis of the Conserved Active-Site Tyrosine Changes a Retaining Sialidase into an Inverting Sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Mechanism of Arthrobacter sialophilus neuraminidase: the binding of substrates and transition-state analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza B virus neuraminidase can synthesize its own inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Glycosidase mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Mutagenesis of glycosidases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Dissection of nucleophilic and acid-base catalysis in glycosidases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Neuraminidase inhibition and viral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The inhibition of neuraminidase and antiviral action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

New ganglioside analogs that inhibit influenza virus sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Inhibition of bacterial and viral sialidases by 3-fluoro-N-acetylneuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Uptake, metabolism and excretion of orally and intravenously administered, double-labeled N-glycoloylneuraminic acid and single-labeled 2-deoxy-2,3-dehydro-N-acetylneuraminic acid in mouse and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

In vitro and in vivo assay systems for study of influenza virus inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The interaction of substrate-related ketals with bacterial and viral neuraminidases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis of transition-state analogues as potential inhibitors of sialidase from Influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified at the C-4 and C-9 positions and their behaviour towards sialidase from influenza virus and pig liver membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Chemoenzymatic synthesis of an N-acetylneuraminic acid analogue having a carbamoylmethyl group at C-4 as an inhibitor of sialidase from influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

2,3-Didehydro-2-deoxysialic acids structurally varied at C-5 and their behaviour towards the sialidase from Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Tethered neuraminidase inhibitors that bind an influenza virus: a first step towards a diagnostic method for influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Analysis of inhibitor binding in influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Sialidase inhibitors related to zanamivir: synthesis and biological evaluation of 4H-pyran 6-ether and ketone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Unsaturated N-acetyl- D-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

An efficient approach to N-acetyl-D-glucosaminuronic acid-based sialylmimetics as potential sialidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Design of N-acetyl-6-sulfo-beta-d-glucosaminide-based inhibitors of influenza virus sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

N-Acetyl-6-sulfo-d-glucosamine as a promising mimic of N-Acetyl neuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Structures of aromatic inhibitors of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Guanidinobenzoic acid inhibitors of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Carbocyclic Analogues of N-Acetyl-2,3-didehydro-2-deoxy-D-neuraminic Acid (Neu5Ac2en, DANA): Synthesis and Inhibition of Viral and Bacterial Neuraminidases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Oseltamivir: a clinical and pharmacological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Antiviral therapy of influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The Synthetic Development of the Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu ® ): A Challenge for Synthesis & Process Research

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Anti-influenza virus activity of peramivir in mice with single intramuscular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Novel alpha- and beta-amino acid inhibitors of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Enantioselective synthesis of antiinfluenza compound A-315675.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Total synthesis of A-315675: a potent inhibitor of influenza neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Structure and diversity of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

Neuraminidase inhibitors as potential anti-influenza drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2807%2961006-3

7 January 2021

10.1016/S0065-2318(07)61006-3

Identifiers

DOI

1 reference

20 June 2017

1 reference